Gordon Carl L

Gordon Carl L is listed in filings as Director at Compass Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including sale activity. Recent filings connect the profile to Compass Therapeutics, Inc. (CMPX), Keros Therapeutics, Inc. (KROS), and Terns Pharmaceuticals, Inc. (TERN). The current snapshot covers public activity from Jun 14, 2024 to Jan 5, 2026. Reported amounts are shown as $465.3K to $1.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.